Climate Change Data Portal
DOI | 10.1073/pnas.2026813118 |
Inactivation of the tumor suppressor p53 by long noncoding RNA RMRP | |
Chen Y.; Hao Q.; Wang S.; Cao M.; Huang Y.; Weng X.; Wang J.; Zhang Z.; He X.; Lu H.; Zhou X. | |
发表日期 | 2021 |
ISSN | 0027-8424 |
卷号 | 118期号:29 |
英文摘要 | p53 inactivation is highly associated with tumorigenesis and drug resistance. Here, we identify a long noncoding RNA, the RNA component of mitochondrial RNA-processing endoribonuclease (RMRP), as an inhibitor of p53. RMRP is overexpressed and associated with an unfavorable prognosis in colorectal cancer. Ectopic RMRP suppresses p53 activity by promoting MDM2-induced p53 ubiquitination and degradation, while depletion of RMRP activates the p53 pathway. RMRP also promotes colorectal cancer growth and proliferation in a p53-dependent fashion in vitro and in vivo. This anti-p53 action of RMRP is executed through an identified partner protein, SNRPA1. RMRP can interact with SNRPA1 and sequester it in the nucleus, consequently blocking its lysosomal proteolysis via chaperone-mediated autophagy. The nuclear SNRPA1 then interacts with p53 and enhances MDM2-induced proteasomal degradation of p53. Remarkably, ablation of SNRPA1 completely abrogates RMRP regulation of p53 and tumor cell growth, indicating that SNRPA1 is indispensable for the anti-p53 function of RMRP. Interestingly and significantly, poly (ADP-ribose) polymerase (PARP) inhibitors induce RMRP expression through the transcription factor C/EBPβ, and RMRP confers tumor resistance to PARP inhibition by preventing p53 activation. Altogether, our study demonstrates that RMRP plays an oncogenic role by inactivating p53 via SNRPA1 in colorectal cancer. © 2021 National Academy of Sciences. All rights reserved. |
英文关键词 | P53 | long noncoding RNA | RMRP | SNRPA1 | PARP inhibition |
语种 | 英语 |
scopus关键词 | CCAAT enhancer binding protein beta; nicotinamide adenine dinucleotide adenosine diphosphate ribosyltransferase inhibitor; protein p53; ribonuclease; RNA binding protein; RNA processing endoribonuclease; small nuclear ribonucleoprotein; unclassified drug; untranslated RNA; long untranslated RNA; mouse double minute 2 homolog; protein binding; protein p53; RMRP non-coding RNA, human; small nuclear ribonucleoprotein; TP53 protein, human; U2A' protein, human; animal cell; animal experiment; animal model; animal tissue; Article; cancer cell culture; cancer growth; cancer inhibition; cancer prognosis; cancer tissue; carcinogenesis; cell cycle progression; cell proliferation; cell viability; cell viability assay; chaperone-mediated autophagy; chromatin immunoprecipitation; colony formation; colorectal cancer; colorectal cancer cell line; CRISPR-CAS9 system; enzyme activity; gene editing; gene expression; gene knockdown; gene overexpression; immunoprecipitation; in situ hybridization; luciferase assay; male; mass spectrometry; mouse; mRNA expression level; nonhuman; overall survival; protein degradation; protein expression; protein interaction; pull-down assay; real time polymerase chain reaction; RNA extraction; RNA immunoprecipitation; RNA processing; RNA sequencing; tumor growth; tumor resistance; tumor volume; tumor xenograft; ubiquitination; colorectal tumor; down regulation; gene expression regulation; genetics; human; metabolism; tumor cell line; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; Protein Binding; Proto-Oncogene Proteins c-mdm2; Ribonucleoprotein, U2 Small Nuclear; RNA, Long Noncoding; Tumor Suppressor Protein p53 |
来源期刊 | Proceedings of the National Academy of Sciences of the United States of America
![]() |
文献类型 | 期刊论文 |
条目标识符 | http://gcip.llas.ac.cn/handle/2XKMVOVA/251120 |
作者单位 | Fudan University Shanghai Cancer Center, Fudan University, Shanghai, 200032, China; Institutes of Biomedical Sciences, Fudan University, Shanghai, 200032, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, 200032, China; Department of Biochemistry & Molecular Biology, Tulane University School of Medicine, New Orleans, LA 70112, United States; Tulane Cancer Center, Tulane University School of Medicine, New Orleans, LA 70112, United States; Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, 200032, China; Shanghai Key Laboratory of Medical Epigenetics, International Co-laboratory of Medical Epigenetics and Metabolism, Ministry of Science and Technology, Institutes of Biomedical Sciences, Fudan University, Shanghai, 200032, China |
推荐引用方式 GB/T 7714 | Chen Y.,Hao Q.,Wang S.,et al. Inactivation of the tumor suppressor p53 by long noncoding RNA RMRP[J],2021,118(29). |
APA | Chen Y..,Hao Q..,Wang S..,Cao M..,Huang Y..,...&Zhou X..(2021).Inactivation of the tumor suppressor p53 by long noncoding RNA RMRP.Proceedings of the National Academy of Sciences of the United States of America,118(29). |
MLA | Chen Y.,et al."Inactivation of the tumor suppressor p53 by long noncoding RNA RMRP".Proceedings of the National Academy of Sciences of the United States of America 118.29(2021). |
条目包含的文件 | 条目无相关文件。 |
个性服务 |
推荐该条目 |
保存到收藏夹 |
导出为Endnote文件 |
谷歌学术 |
谷歌学术中相似的文章 |
[Chen Y.]的文章 |
[Hao Q.]的文章 |
[Wang S.]的文章 |
百度学术 |
百度学术中相似的文章 |
[Chen Y.]的文章 |
[Hao Q.]的文章 |
[Wang S.]的文章 |
必应学术 |
必应学术中相似的文章 |
[Chen Y.]的文章 |
[Hao Q.]的文章 |
[Wang S.]的文章 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。